Moderna Pitch Deck

Moderna Inc. is a biotechnology company at the forefront of messenger RNA (mRNA) therapeutics and vaccines. With a focus on developing innovative drugs, Moderna utilizes mRNA technology to stimulate protein or antibody production within patient cells. Their diverse pipeline encompasses prophylactic vaccines, therapeutic vaccines, intratumoral immuno-oncology, localized therapeutics, and liver intracellular treatments. Leveraging their mRNA therapeutics platform, Moderna pioneers the development and production of human proteins, antibodies, and novel proteins for disease prevention, treatment, and cure. They are actively involved in infectious disease, rare liver disease, immuno-oncology, and cardiovascular disease therapeutics.

$500M • 2017 • Series G